🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-center, Phase II trial designed to estimate i...
Status
Unknown
Location
Istituto Clinico Humanitas
Start Date
2020-01-30
Trial ID
NCT04435977
Treatments Being Tested
This phase I trial evaluates the effects of CBM588 in combination with stan...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2021-11-01
Trial ID
NCT05122546
Treatments Being Tested
This research study, is studying the combination of cabozantinib and nivolu...
Status
Completed
Location
Boston Medical Center
Start Date
2019-12-26
Trial ID
NCT04197310
Treatments Being Tested
This research is being done to study the safety and feasibility of implanti...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-12-01
Trial ID
NCT05700461
Treatments Being Tested
This phase I trial studies the side effects and best dose of cabozantinib-s...
Status
Terminated
Location
Emory University/Winship Cancer Institute
Start Date
2013-05
Trial ID
NCT01835184
Treatments Being Tested
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
This is a non-interventional study to retrospectively evaluate the safety a...
Status
Terminated
Location
Uniklinik Essen
Start Date
2019-03-08
Trial ID
NCT04147143
Treatments Being Tested
This phase II trial studies how well cabozantinib-s-malate works in treatin...
Status
Completed
Location
MedStar Georgetown University Hospital
Start Date
2013-05-08
Trial ID
NCT01811212
Treatments Being Tested
This is a phase II study to assess the efficacy, safety, and Health Related...
Status
Recruiting
Location
Ryan Nguyen
Start Date
2022-12-28
Trial ID
NCT05613413
Treatments Being Tested
The purpose of the CaboAveNEC trial is to investigate the clinical activity...
Status
Unknown
Location
Nationales Centrum für Tumorerkrankungen, Universitätsklinikum Heidelberg
Start Date
2022-03-28
Trial ID
NCT05289856
Treatments Being Tested